Get the Stockscreener App
2.09
5.00%
-0.11
Elutia Inc stock is traded at $2.09, with a volume of 50,950.
It is down -5.00% in the last 24 hours and down -0.48% over the past month.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
See More
Previous Close:
$2.20
Open:
$2.27
24h Volume:
50,950
Relative Volume:
2.04
Market Cap:
$76.92M
Revenue:
$24.38M
Net Income/Loss:
$-53.95M
P/E Ratio:
-0.8462
EPS:
-2.47
Net Cash Flow:
$-23.31M
1W Performance:
+3.47%
1M Performance:
-0.48%
6M Performance:
-35.09%
1Y Performance:
-47.88%
1-Day Range:
$2.07
$2.27
1-Week Range:
$1.96
$2.27
52-Week Range:
$1.61
$5.12
Elutia Inc Stock (ELUT) Company Profile
Name
Elutia Inc
Sector
Industry
Phone
240-247-1143
Address
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
2.09 | 83.05M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-02-20 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-02-20 | Initiated | Cowen | Outperform |
| Nov-02-20 | Initiated | Piper Sandler | Overweight |
| Nov-02-20 | Initiated | Truist | Buy |
Elutia Inc Stock (ELUT) Latest News
Elutia Inc. Amends Credit Agreement with SWK Funding - TipRanks
Elutia enters fifth amendment to credit agreement - MarketScreener
How to manage a losing position in Elutia Inc.Trade Entry Report & Free Verified High Yield Trade Plans - Newser
Will Elutia Inc. face regulatory challengesGlobal Markets & Real-Time Volume Surge Alerts - sisa-n.com
Elutia Inc. stock momentum explainedMarket Activity Recap & Daily Volume Surge Signals - Newser
Will Elutia Inc. continue its uptrend2025 Support & Resistance & Daily Oversold Bounce Ideas - Newser
Real time pattern detection on Elutia Inc. stockMarket Rally & Smart Investment Allocation Tips - Newser
Using RSI to spot recovery in Elutia Inc.Swing Trade & Expert Curated Trade Setups - Newser
Using fundamentals and technicals on Elutia Inc.July 2025 Rallies & Community Supported Trade Ideas - Newser
What does recent volatility data suggest for Elutia Inc.Bull Run & Fast Exit/Entry Strategy Plans - Newser
US$6.50: That's What Analysts Think Elutia Inc. (NASDAQ:ELUT) Is Worth After Its Latest Results - simplywall.st
Analysts Have Been Trimming Their Elutia Inc. (NASDAQ:ELUT) Price Target After Its Latest Report - Yahoo Finance
Elutia targets $20M EluPro revenue run rate and NXT-41 launch in H2 2026 while advancing hospital penetration - MSN
Elutia Posts Earnings Miss in Q2 2025; Market Reacts with Short-Term Optimism - AInvest
What makes Elutia Inc. stock price move sharply2025 Investor Takeaways & Safe Capital Growth Plans - Newser
How to recover losses in Elutia Inc. stockPortfolio Gains Report & Weekly Market Pulse Alerts - Newser
What is Elutia Inc.’s valuation compared to sector2025 Earnings Impact & Consistent Income Trade Ideas - newsyoung.net
Elutia Misses Q2 Earnings, but Market Shows Optimistic Short-Term Reaction - AInvest
Does Elutia Inc. fit your quant trading modelOil Prices & Short-Term High Return Ideas - Newser
Detecting price anomalies in Elutia Inc. with AIPortfolio Return Summary & Verified Swing Trading Watchlists - Newser
Can Elutia Inc. rally from current levelsEarnings Growth Summary & Daily Entry Point Trade Alerts - Newser
Volume spikes in Elutia Inc. stock – what they meanJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - Newser
What technical models suggest about Elutia Inc.’s comebackMarket Movers & Fast Exit Strategy with Risk Control - Newser
Using Python tools to backtest Elutia Inc. strategiesTrade Ideas & AI Optimized Trading Strategy Guides - Newser
Detecting support and resistance levels for Elutia Inc.Quarterly Risk Review & Weekly Chart Analysis and Trade Guides - Newser
Analyzing net buyer seller activity in Elutia Inc.Stop Loss & Momentum Based Trading Signals - Newser
Is Elutia Inc. part of any ETFWeekly Loss Report & Risk Controlled Swing Alerts - sundaytimes.kr
Is Elutia Inc. a play on infrastructure spending2025 AllTime Highs & Daily Profit Focused Stock Screening - thegnnews.com
Developing predictive dashboards with Elutia Inc. dataExit Point & AI Powered Buy/Sell Recommendations - Newser
Will Elutia Inc. Stock Benefit from AI and Green Energy TrendsJuly 2025 Drop Watch & Accurate Buy Signal Alerts - Newser
Does Elutia Inc. have strong fundamentalsJuly 2025 Setups & Low Risk High Win Rate Stock Picks - thegnnews.com
Elutia Inc reports results for the quarter ended June 30Earnings Summary - TradingView
How Elutia Inc. stock performs during market volatility2025 Key Lessons & Free Accurate Trade Setup Notifications - Newser
Elutia Inc (ELUT) Q2 2025 Earnings Call Highlights: Strong EluPro Growth Amid Financial Challenges - Yahoo Finance
Elutia 2025 Q2 Earnings Narrower Losses Despite Revenue Decline - AInvest
Elutia Inc. Reports Strong Growth and Strategic Advances - TipRanks
Elutia's Q2 2025: Unpacking Contradictions in Demand, Production, and Growth Strategies - AInvest
Elutia Inc. (ELUT): A High-Conviction Growth Story in Biologics-Driven MedTech - AInvest
Is There Enough Volume to Lift Elutia Inc.2025 Breakouts & Breakdowns & Weekly Sector Rotation Insights - thegnnews.com
Elutia (ELUT) Q2 2025 Earnings Call Transcript - The Globe and Mail
Elutia Q2 2025 slides: EluPro drives growth amid cash concerns By Investing.com - Investing.com Canada
Elutia (ELUT): Navigating the Crossroads of Innovation and Profitability in a High-Stakes Market - AInvest
ELUTIA INC. SEC 10-Q Report - TradingView
ELUTIA Earnings Results: $ELUT Reports Quarterly Earnings - Quiver Quantitative
Elutia earnings missed by $0.07, revenue fell short of estimates - Investing.com Canada
Elutia reports 49% sequential growth in EluPro Q2 revenue By Investing.com - Investing.com South Africa
Elutia Inc Stock (ELUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Elutia Inc Stock (ELUT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HighCape Capital, L.P. | Director |
Feb 03 '25 |
Buy |
2.50 |
420,000 |
1,050,000 |
9,520,232 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):